UNIVERSITY OF PENNSYLVANIA MEDICAL CENTER
GUIDELINES FOR ANTIBIOTIC USE
PROPHYLAXIS MEDICATION GUIDELINES FOR LIVER TRANSPLANT
| Indication | Patient Population | Medication | Dose | Duration of Therapy |
|---|---|---|---|---|
Antiviral |
All Patients | ganciclovir | 6 mg/kg IV qd1 |
48 hrs post-op until CMV D/R status is established |
| CMV D+/R- | ganciclovir | 6 mg/kg IV qd1 | 100 days | |
| CMV D+/R+ OR CMV D-/R+ | acyclovir | 800 mg PO tid2 | 90 days | |
| CMV D-/R- | acyclovir | 800 mg PO tid2 | 90 days | |
Antifungal |
All patients | nystatin | 5cc Swish/Swallow tid | 90 days |
Patients with: 1) Renal failure (SCr > 3.0) pre-transplant 2) Re-operation (including re-transplantation) 3) Prolonged operative course (> 8 hrs) 4) Roux-en-Y 5) Pre-transplant fungal colonization 6) "massive" intraoperative blood transfusions |
fluconazole | 200 mg PO qd3 | At least one week post-transplant | |
PCP |
All patients | cotrimoxazole4 | 1 SS tablet PO qd | 365 days |
GI |
All patients | ranitidine5 | 150 mg PO bid | While on steroid therapy only unless there is a pre-existing need. |
Hepatitis B |
Hep B Surface Ag Positive recipients and recipients of a Hep B Core Antibody Positive Donor | lamivudine (should be Epivir-HBV brand)6 | 100 mg PO qd | Indefinitely |
| All patients receiving a liver from a Hep B Core Antibody Positive Donor | HBIG (Hep B Immune globulin) | 10,000 units qd7,8 | 3 doses | |
| Any recipient who is Hep B Surface Antigen Positive | HBIG | 10,000 units qd7,8 x 7 days then 10,000 units each week x 4 weeks then 10,000 units every month x 4 months |
||
1 Adjust for renal insufficiency:
| CrCL > 70 ml/min | 6 mg/kg qd |
| CrCL 50 - 70 ml/min | 3 mg/kg qd |
| CrCL 25 - 50 ml/min | 1.5 mg/kg qd |
| CrCL 10 - 25 ml/min | 0.75 mg/kg qd |
| CrCL < 10 ml/min | 0.75 mg/kg three times weekly after dialysis |
| CVVHD | 2.5 mg/kg qd |
2 Adjust for renal insufficiency.
3 May give fluconazole 200 mg IV qd if patient cannot tolerate oral medications. Needs adjustment for renal insufficiency.
4 Cotrimoxazole is sulfamethoxazole + trimethoprim; trade names include Septra and Bactrim. A single strength (SS) cotrimoxazole tablet contains 80 mg trimethoprim and 400 mg sulfamethoxazole. If sulfa allergy: start atovaquone suspension 1500 mg PO qd. If unable to take atovaquone then check G6PD deficiency and if NOT deficient start dapsone 100 mg PO qd. If G6PD deficient check with nephrologist for alternative therapy. May need adjustment for renal insufficiency.
5 If already on a proton pump inhibitor (PPI) then continue that agent. Ranitidine needs dosage adjustment for renal insufficiency: >50 ml/min, 150 po bid; <50, 150 mg po once daily; hemodialysis, 150 mg po once daily, with administration of dose after dialysis on dialysis day.
6 Adjust for renal insufficiency
7 Infuse over 6 hours for first dose and if tolerated, 4 hours for each subsequent dose.
8 After 6 months HBIG titers will be drawn. Dose and frequency is adjusted based on titers drawn prior to infusions.
Anti-infective Prophylaxis During Treatment of Rejection Episodes |
|
|---|---|
| Treatment with Thymoglobulin, OKT3, or ATGAM | Restart PCP and antiviral prophylaxis per above guidelines. Do not restart antifungal prophylaxis |
| Pulse Dose Steroids Alone | Do not restart any anti-infective prophylaxis |
written by Emily Blumberg and Lori LaRosa, October 2005